Related Experiment Video

Updated: Aug 21, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Advances in the management of Chlamydia pneumoniae infections

Margaret R Hammerschlag1

  • 1Division of Pediatric Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, NY 11203-2098, USA. mhammerschlag@pol.net

Expert Review of Anti-Infective Therapy
|October 16, 2004
PubMed

Insights

Chlamydia pneumoniae causes prolonged infections linked to chronic diseases. While antibiotics effectively eradicate it from the respiratory tract, reliable markers for chronic infections are lacking, complicating treatment assessment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pathogenesis

Background:

  • Chlamydia spp. are known for causing prolonged, often subclinical infections.
  • Chronic Chlamydia pneumoniae infection is implicated in the development of chronic diseases such as asthma, arthritis, and atherosclerosis.
  • Chlamydia pneumoniae exhibits in vitro susceptibility to various antibiotics targeting protein or DNA synthesis.

Purpose of the Study:

  • To review the efficacy of antimicrobial agents against Chlamydia pneumoniae.
  • To assess the challenges in diagnosing and treating chronic Chlamydia pneumoniae infections, particularly in cardiovascular disease.

Main Methods:

  • Review of existing literature on Chlamydia pneumoniae treatment studies.
  • Analysis of studies utilizing culture and serology for diagnosis and treatment evaluation.

Main Results:

  • Antibiotics like erythromycin, azithromycin, clarithromycin, levofloxacin, and moxifloxacin show 70-90% efficacy in eradicating C. pneumoniae from the respiratory tract in pneumonia cases.
  • Antibiotic resistance does not appear to be the cause of persistent C. pneumoniae.
  • Current serological methods are inadequate for diagnosing chronic or persistent C. pneumoniae infections.

Conclusions:

  • While respiratory tract infections with C. pneumoniae are treatable, extrapolating this to chronic conditions like cardiovascular disease is not currently possible.
  • The lack of reliable diagnostic markers for chronic C. pneumoniae infection hinders the assessment of treatment effectiveness.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment